Glympse Bio has developed sensor technology that it says can give clinicians an early look at a developing disease. As Glympse prepares to test its disease detection approach in a serious liver disorder, the startup has raised $22 million in Series A financing. LS Polaris Innovation Fund and Arch Venture Partners co-led the investment in Cambridge, […]